INVESTORS

Pioneering a new standard in restorative medicine

RTST Pharma offers a unique opportunity to invest in a pharmaceutical startup that is successfully bridging the gap between everyday lifestyle needs and rigorous clinical standards. Based in Pittsford, New York, we are addressing a significant unmet medical need by developing the world’s first evidence-based therapy for hangovers.

  • First-to-Market Advantage

    We are capturing an underserved global market with the first evidence-based solution of its kind.

  • Clinical Credibility

    Our development is rooted in data-driven research, prioritizing patient safety and measurable therapeutic outcomes.

  • Scalable Innovation

    Beyond Revognah, our framework is designed to launch a pipeline of consumer-centric, preventive healthcare products.

  • Regulatory Focus

    We mitigate risk by aligning our formulation and manufacturing strategies with strict pharmaceutical and FDA benchmarks.
investor-img

Our flagship product, Revognah, represents a breakthrough in metabolic recovery, backed by a commitment to future FDA standards. We invite partners who value scientific integrity and social consciousness to join us as we lead the transition from unregulated supplements to professional-grade therapeutics. Together, we can redefine the recovery market through innovation and compassion.